DE69409471T2 - Amidinophenolderivate mit Phospholipase A2 inhibitorischer Wirkung - Google Patents

Amidinophenolderivate mit Phospholipase A2 inhibitorischer Wirkung

Info

Publication number
DE69409471T2
DE69409471T2 DE69409471T DE69409471T DE69409471T2 DE 69409471 T2 DE69409471 T2 DE 69409471T2 DE 69409471 T DE69409471 T DE 69409471T DE 69409471 T DE69409471 T DE 69409471T DE 69409471 T2 DE69409471 T2 DE 69409471T2
Authority
DE
Germany
Prior art keywords
phospholipase
formula
inhibitory activity
pancreatitis
chem
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69409471T
Other languages
English (en)
Other versions
DE69409471D1 (de
Inventor
Hisao Nakai
Koumei Kamiyasu
Masanori Kawamura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ono Pharmaceutical Co Ltd
Original Assignee
Ono Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ono Pharmaceutical Co Ltd filed Critical Ono Pharmaceutical Co Ltd
Publication of DE69409471D1 publication Critical patent/DE69409471D1/de
Application granted granted Critical
Publication of DE69409471T2 publication Critical patent/DE69409471T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
    • C07C257/10—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
    • C07C257/18—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having carbon atoms of amidino groups bound to carbon atoms of six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/02—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups
    • C07C251/24—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups having carbon atoms of imino groups bound to carbon atoms of six-membered aromatic rings
DE69409471T 1993-12-03 1994-12-01 Amidinophenolderivate mit Phospholipase A2 inhibitorischer Wirkung Expired - Fee Related DE69409471T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP30404893 1993-12-03

Publications (2)

Publication Number Publication Date
DE69409471D1 DE69409471D1 (de) 1998-05-14
DE69409471T2 true DE69409471T2 (de) 1998-08-27

Family

ID=17928422

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69409471T Expired - Fee Related DE69409471T2 (de) 1993-12-03 1994-12-01 Amidinophenolderivate mit Phospholipase A2 inhibitorischer Wirkung

Country Status (10)

Country Link
US (1) US5514713A (de)
EP (1) EP0656349B1 (de)
KR (1) KR0185678B1 (de)
CN (1) CN1035998C (de)
AT (1) ATE164834T1 (de)
CA (1) CA2137106C (de)
DE (1) DE69409471T2 (de)
DK (1) DK0656349T3 (de)
ES (1) ES2115887T3 (de)
TW (1) TW419454B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE178589T1 (de) 1994-09-20 1999-04-15 Ono Pharmaceutical Co Amidinophenol-derivate als protease-hemmende verbindungen
WO1997037969A1 (fr) 1996-04-10 1997-10-16 Ono Pharmaceutical Co., Ltd. Inhibiteur de tryptase derives de guanidino
WO1998013347A1 (en) * 1996-09-26 1998-04-02 Novartis Ag Aryl-substituted acrylamides with leukotriene b4 (ltb-4) receptor antagonist activity
AU3731400A (en) * 1999-03-05 2000-09-21 Trustees Of University Technology Corporation, The Methods and compositions useful in inhibiting apoptosis
US6849605B1 (en) * 1999-03-05 2005-02-01 The Trustees Of University Technology Corporation Inhibitors of serine protease activity, methods and compositions for treatment of viral infections
AU3511500A (en) 1999-03-05 2000-09-21 Trustees Of University Technology Corporation, The Inhibitors of serine protease activity, methods and compositions for treatment of nitric oxide-induced clinical conditions
WO2000051625A1 (en) * 1999-03-05 2000-09-08 The Trustees Of University Technology Corporation Inhibitors of serine protease activity, methods and compositions for treatment of herpes viruses
US20040220242A1 (en) * 2003-05-02 2004-11-04 Leland Shapiro Inhibitors of serine protease activity, methods and compositions for treatment of nitric oxide induced clinical conditions
EP2520654B8 (de) 2003-08-26 2017-04-19 The Regents of the University of Colorado, a body corporate Serinprotease-Hemmer und deren Verwendung in Verfahren und Zusammensetzungen für die Behandlung bakterieller Infektionen
WO2006057152A1 (ja) * 2004-11-08 2006-06-01 Ono Pharmaceutical Co., Ltd. タンパク質分解酵素阻害化合物からなる糖尿病治療剤
US20100063146A1 (en) * 2006-11-07 2010-03-11 Medof M Edward Method for treating disorders related to complement activation
GB2445920A (en) * 2007-01-25 2008-07-30 Mucokinetica Ltd Amidino compounds for treatment of respiratory disease
KR20120006059A (ko) * 2009-04-17 2012-01-17 메르츠 파마 게엠베하 운트 코. 카가아 1-아미노-1,3,3,5,5-펜타메틸사이클로헥산 메실레이트의 합성
CN102225903B (zh) * 2011-04-21 2014-11-26 任建东 脒基胍基取代芳杂环类化合物的合成方法及其用途
CN102491921A (zh) * 2011-12-13 2012-06-13 苏州瑞辉生物医药研发中心有限公司 一种4-胍基苯甲酸（4-甲氧甲酰基）苯酯甲烷磺酸盐的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE555319A (de) * 1956-03-21 1900-01-01
US3095355A (en) * 1961-10-12 1963-06-25 Revlon Aerosol composition
GB2095239B (en) * 1981-02-27 1985-03-06 Torii & Co Ltd Novel amidine compounds
JP3220225B2 (ja) * 1992-04-10 2001-10-22 小野薬品工業株式会社 グアニジノフェノール誘導体

Also Published As

Publication number Publication date
EP0656349B1 (de) 1998-04-08
CN1110679A (zh) 1995-10-25
DE69409471D1 (de) 1998-05-14
KR0185678B1 (ko) 1999-05-15
EP0656349A1 (de) 1995-06-07
TW419454B (en) 2001-01-21
CA2137106A1 (en) 1995-06-04
ATE164834T1 (de) 1998-04-15
KR950017929A (ko) 1995-07-20
US5514713A (en) 1996-05-07
CN1035998C (zh) 1997-10-01
ES2115887T3 (es) 1998-07-01
DK0656349T3 (da) 1998-06-02
CA2137106C (en) 2000-02-08

Similar Documents

Publication Publication Date Title
DE69409471T2 (de) Amidinophenolderivate mit Phospholipase A2 inhibitorischer Wirkung
DE69329996D1 (de) Inhibitoren retroviraler proteasen
BR9707010A (pt) Derivados de aminoácidos sulfonados e inibidores de metalproteinase contendo os mesmos
ATE171165T1 (de) 2- (dihydro)pyrazolyl-3'-oxymethylen>-anilide als schädlingsbekämpfungsmittel und fungizide
DK0449216T3 (da) 3,5-Di-tertiærbutyl-4-hydroxyphenylmethylenderivater af 2-substituerede thiazolidinoner, oxazolidinoner og imidazolidinoner som antiinflammatoriske midler
DE69132435D1 (de) Inhibitoren retroviraler Proteasen
DE69526330D1 (de) Serin-protease-inhibitoren: derivate des isothiazolidin-3-on-1,1-dioxids und des 3-oxo-1,2,5-thiadiazolidin-1,1-dioxids
FI915819A (fi) Hiv- proteas-inhibitorer.
CA2226256A1 (en) New thrombin inhibitors, their preparation and use
FI935172A0 (fi) Inhibitorer av katepsin G och elastas foer foerhindrande degeneration avbindvaevnad
DE69011305T2 (de) Cyclopropylderivate als Lipoxygenase-Inhibitoren.
ATE147724T1 (de) Arylamidoalkyl- und arylaminoalkyl- n- hydroxyharnstoff- und n- hydroxyameisensäureamidderivate mit lipoxygenase inhibierenden aktivität
ATE162181T1 (de) Phenylalkan(en)-säuren mit leukotriene b4 antagonistischer wirkung
DK0703216T3 (da) Amidinophenolderivater som proteaseinhibitorer
BR9612074A (pt) Novos 4-(1h-benzimidazol-2-il)(1,4) diazepanos substituidos úteis para o tratamento de doenças alérgicas
NO964269L (no) 2,3-dihydroksypropyl 2-(1-oksoalkyl)amino-2-deoksogluco-pyranosider, deres fremstilling og anvendelse
EP0466944A4 (en) 4h-3,1-benzoxazin-4-one compound and elastase inhibitor composition containing the same
ES2104463T3 (es) Nuevos derivados de la serina; su preparacion y su utilizacion en las composiciones cosmeticas o dermatologicas.
DE69720521D1 (de) Hemmer der subepithelialen turbidität
ATE126965T1 (de) Synergistische herbizide mittel.
ID20165A (id) Penggunaan asam 2-(3,4-dimetoksisinamoil)aminobenzoat untuk pembuatan obat untuk pengobatan atau pencegahan restenosis
ATE229963T1 (de) Phosphinsäurederivate mit metallopeptidase- inhibitorischer wirkung
ES2062332T3 (es) Benzoxazolonas antiinflamatorias.
DE69810724T2 (de) Verwendung von Protein C Inhibitor zur Behandlung disseminierter intravasaler Gerinnung (DIC)
IT1263041B (it) Derivati di s,s'-bis(carbossammidofenil)-disolfuro ad attivita' cardiovascolare

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee